PLX 250117 2.50C (PLX250117C2500) Stock Options, News & Quotes

English
中文繁體
中文简体

Download

Mobile

Moomoo Desktop

The next-gen workspace

Download now

Click to view more download content

English
中文繁體
中文简体

Dark
Light

Open Account

Download

US OptionsDetailed Quotes

PLX250117C2500

Watchlist

0.04
0.000.00%

15min DelayClose Jan 3 16:00 ET

0.10High0.04Low

Intraday

5D
Daily

News

NYSE American New 52-Week Highs And Lows
Dow JonesJan 2 15:22 ET
Chiesi Global Rare Diseases and Protalix BioTherapeutics Announce Validation of Variation Submission by European Medicines Agency for Pegunigalsidase Alfa
PR NewswireDec 9, 2024 06:30 ET
Protalix BioTherapeutics, Inc. (PLX) Q3 2024 Earnings Call Transcript Summary
moomoo AINov 14, 2024 11:35 ET · Conference Call
Protalix BioTherapeutics Reports Profit In Q3; Announces Positive Phase 1 Data For PRX-115
RTTNewsNov 14, 2024 07:48 ET
Protalix BioTherapeutics Q3 24 Earnings Conference Call At 8:30 AM ET
RTTNewsNov 14, 2024 07:34 ET
Protalix Biotherapeutics | 10-Q: Q3 2024 Earnings Report
SECNov 14, 2024 07:07 ET · Announcements

Comments

Jaguar8

Oct 25, 2024 06:43

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present Phase I PRX-115 Data in Late-Breaking Poster at ACR Convergence 2024
Protalix BioTherapeutics (NYSE American:PLX) announced it will present data from its phase I clinical trial of PRX-115, a recombinant PEGylated uricase product candidate for uncontrolled gout treatment, at the ACR Convergence 2024. The presentation, titled 'Prolonged Plasma Urate-Lowering After a Single Intravenous Administration of PRX-115,' will be del...

Jaguar8

Jun 13, 2024 06:35

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Host In-Person Investor Day to Discuss Current Treatment Landscapes and Clinical Results for Fabry Disease and Uncontrolled Gout
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical firm, will host an in-person investor day on June 26, 2024, at the Lotte Palace New York Hotel. The event will begin at 8:30 a.m. EDT. Key opinion leaders, including Aleš Linhart of Charles University and Naomi Schlesinger of the Univers...

Jaguar8

May 29, 2024 07:40

NEWS

$Protalix Biotherapeutics (PLX.US)$
Protalix BioTherapeutics to Present at the 2024 BIO International Convention
Protalix BioTherapeutics (NYSE American: PLX), a biopharmaceutical company specializing in recombinant therapeutic proteins via its ProCellEx® plant cell-based system, announced its participation at the 2024 BIO International Convention in San Diego, California. The convention, hosted by the Biotechnology Innovation Organization (BIO), is the largest industry event, gathering glo...

AmyNic

May 10, 2023 05:21

Going for the retest

$Protalix Biotherapeutics (PLX.US)$

AmyNic

May 10, 2023 04:35

Wow wtf lol

$Protalix Biotherapeutics (PLX.US)$